Andrew J. Einhorn
Director · Pelthos Therapeutics Inc.
Individual
- 2025
- Dec 29, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew J. Einhorn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd C. Davis - $1000K in PTHS purchases and sales in the last 12 months
- Ezra M. Friedberg - $326K in PTHS purchases and sales in the last 12 months
- Peter Greenleaf - $54K in PTHS purchases and sales in the last 12 months
- Matthew Pauls - $54K in PTHS purchases and sales in the last 12 months
- Knuettel Francis II - $40K in PTHS purchases and sales in the last 12 months
- Richard Malamut - $12K in PTHS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew J. Einhorn?
Andrew J. Einhorn is a corporate insider, tracked as Director of Pelthos Therapeutics Inc. (PTHS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew J. Einhorn last file a Form 4?
The only primary Form 4 on record is dated 29 December 2025.
